Fiche centre
The First Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou — China
Essais liés4clinical trials
VilleHangzhoulocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06875310
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| B007 | Myasthénie | Phase 2/3 | NCT06447597 | A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. | RECRUITING |
| Adagrasib | Cancer | Phase 3 | NCT06875310 | A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) | RECRUITING |
| Tizanidine Hydrochloride | Migraine | Phase 3 | NCT05484349 | TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME） | UNKNOWN |
| IASO-782 injection | Lupus | Phase 1 | NCT07483346 | IASO-782 in Systemic Lupus Erythematosus | RECRUITING |